Freestone Grove Partners LP Purchases Shares of 177,651 Teladoc Health, Inc. (NYSE:TDOC)

Freestone Grove Partners LP bought a new position in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 177,651 shares of the health services provider's stock, valued at approximately $1,615,000. Freestone Grove Partners LP owned approximately 0.10% of Teladoc Health at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of TDOC. Versant Capital Management Inc raised its position in Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after acquiring an additional 2,441 shares during the period. Whipplewood Advisors LLC acquired a new position in Teladoc Health during the fourth quarter worth about $29,000. Lindbrook Capital LLC boosted its position in shares of Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after buying an additional 1,612 shares in the last quarter. Sterling Capital Management LLC lifted its position in shares of Teladoc Health by 776.7% in the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock valued at $42,000 after acquiring an additional 4,101 shares in the last quarter. Finally, Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Teladoc Health in the fourth quarter valued at $60,000. 76.82% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts recently issued reports on TDOC shares. Oppenheimer reduced their price objective on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research note on Friday, January 24th. Piper Sandler dropped their price objective on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research note on Thursday, February 27th. Citigroup lowered their target price on Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a report on Friday, April 25th. Evercore ISI dropped their price objective on Teladoc Health from $8.00 to $7.00 and set an "in-line" rating on the stock in a research note on Thursday, May 1st. Finally, The Goldman Sachs Group reduced their price target on Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a research note on Thursday, May 1st. Twelve research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, Teladoc Health has an average rating of "Hold" and an average target price of $9.71.

Teladoc Health Stock Up 4.6 %

TDOC traded up $0.32 on Thursday, hitting $7.18. 2,674,388 shares of the company were exchanged, compared to its average volume of 6,254,472. Teladoc Health, Inc. has a 12 month low of $6.35 and a 12 month high of $15.21. The stock's fifty day moving average is $7.83 and its 200-day moving average is $9.44. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The company has a market cap of $1.26 billion, a PE ratio of -1.24 and a beta of 1.82.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The firm had revenue of $640.49 million during the quarter, compared to the consensus estimate of $639.44 million. Equities research analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Insider Activity

In other news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the transaction, the insider now owns 64,308 shares of the company's stock, valued at approximately $541,473.36. This represents a 14.62 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.58% of the stock is owned by corporate insiders.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.